Ophthalmology Times: March 1, 2020
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
Ophthalmic care uncommon after tamoxifen initiation
3
Retinal gene therapy in 2026: 13 milestones from January through October
4
FDA aligns with VeonGen on pivotal phase 3 design for VG801 dual-AAV gene therapy in Stargardt disease
5